Renewing Uplizna (Inebilizumab) Approval with Aetna CVS Health in North Carolina: Timeline, Evidence, and Lapse Prevention
Answer Box: Renewing Uplizna Coverage with Aetna CVS Health
Uplizna (inebilizumab) renewal with Aetna CVS Health in North Carolina requires prior authorization submission 30-60 days before current approval expires. Key evidence: documented clinical response (no relapses for NMOSD, organ stability for IgG4-RD), current specialist evaluation, safety labs (immunoglobulins, B-cell counts)